Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies

C. Spalluto (Southampton, United Kingdom), A. Watson (Southampton, United Kingdom), C. Mccrae (Gothenburg, Sweden), D. Cellura (Southampton, United Kingdom), H. Burke (Southampton, United Kingdom), D. Cunoosamy (Gothenburg, Sweden), A. Freeman (Southampton, United Kingdom), A. Hicks (Southampton, United Kingdom), M. Hühn (Gothenburg, Sweden), K. Ostridge (Southampton, United Kingdom), K. Staples (Southampton, United Kingdom), O. Vaarala (Gothenburg, Sweden), T. Wilkinson (Southampton, United Kingdom)

Source: International Congress 2019 – Mechanisms underlying respiratory infection
Session: Mechanisms underlying respiratory infection
Session type: Poster Discussion
Number: 5441
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Spalluto (Southampton, United Kingdom), A. Watson (Southampton, United Kingdom), C. Mccrae (Gothenburg, Sweden), D. Cellura (Southampton, United Kingdom), H. Burke (Southampton, United Kingdom), D. Cunoosamy (Gothenburg, Sweden), A. Freeman (Southampton, United Kingdom), A. Hicks (Southampton, United Kingdom), M. Hühn (Gothenburg, Sweden), K. Ostridge (Southampton, United Kingdom), K. Staples (Southampton, United Kingdom), O. Vaarala (Gothenburg, Sweden), T. Wilkinson (Southampton, United Kingdom). Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies. 5441

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections
Source: International Congress 2017 – Scientific year in review
Year: 2017


Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies
Source: International Congress 2019 – Scientific Year in review
Year: 2019


Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
Source: Eur Respir J, 55 (6) 2000858; 10.1183/13993003.00858-2020
Year: 2020



The role of virus infections in asthma: immune responses and future possibilities
Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection
Year: 2007



New insights into immunological responses to infection in bronchiectasis
Source: Eur Respir J, 53 (2) 1802395; 10.1183/13993003.02395-2018
Year: 2019



Update on management of new emerging acute respiratory viral infectious diseases
Source: International Congress 2018 – Chinese Programme 2018: Part I
Year: 2018


Improving the innate immune response in respiratory infections: the use of repurposed drugs
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020


Cationic host defence peptides as a novel treatment for respiratory viral infections
Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung
Year: 2018


The immunology of virus infection in asthma
Source: Eur Respir J 2001; 18: 1013-1025
Year: 2001



Influenza virus-induced lung injury: pathogenesis and implications for treatment
Source: Eur Respir J 2015; 45: 1463-1478
Year: 2015



Viruses in asthma and COPD: mechanisms and defence
Source: Annual Congress 2005 - Microorganisms: good, bad or ugly in allergic respiratory disease
Year: 2005

Prevention and treatment of viral infections: CMV and other community respiratory viruses
Source: ERS Course 2016
Year: 2016



Pathomechanisms mediating bacterial co-infection following respiratory viral disease
Source: Lung Science Conference 2015
Year: 2015